Description
Adenuric, containing the active ingredient febuxostat, is a medication primarily prescribed for the management of hyperuricemia in patients with gout. Hyperuricemia is characterized by elevated levels of uric acid in the blood, leading to the formation of urate crystals that can cause painful gout attacks. Adenuric effectively lowers uric acid levels by inhibiting the enzyme xanthine oxidase, which plays a crucial role in uric acid production. This medication helps prevent gout flare-ups and promotes better joint health in individuals suffering from this condition.